Cite
A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection
MLA
David Snydman, et al. A Further Analysis of the Use of Cytomegalovirus Immune Globulin in Orthotopic Liver Transplant Patients at Risk for Primary Infection. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..063079ae1d6124e4eb3dcf533b22c47e&authtype=sso&custid=ns315887. Accessed 24 Jan. 2025.
APA
David Snydman, Werner, B. G., Dougherty, N. N., Griffith, J., Rohrer, R. H., Freeman, R., Jenkins, R., Lewis, W. D., O Rourke, E., Fawaz, K., Hoffman, M. A., Kaplan, M., Barefoot, L., Rubin, R. H., Dienstag, J. L., Doran, M., Vacanti, J., Hammer, S., & Martin, M. (n.d.). A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection.
Chicago
David Snydman, B. G. Werner, N. N. Dougherty, J. Griffith, R. H. Rohrer, R. Freeman, R. Jenkins, et al. 2025. “A Further Analysis of the Use of Cytomegalovirus Immune Globulin in Orthotopic Liver Transplant Patients at Risk for Primary Infection.” Accessed January 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..063079ae1d6124e4eb3dcf533b22c47e&authtype=sso&custid=ns315887.